• Nenhum resultado encontrado

Rev. Assoc. Med. Bras. vol.61 número5

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Assoc. Med. Bras. vol.61 número5"

Copied!
1
0
0

Texto

(1)

FRESH AND GOOD NEWS

REV ASSOC MED BRAS 2015; 61(5):389 389

EDITORIAL

Fresh and good news

N

OVAS E BOAS NOTÍCIAS

CARLOS V. SERRANO JR.1

1Editor-in-Chief, Journal of the Brazilian Medical Association (Ramb, Revista da Associação Médica Brasileira), São Paulo, SP, Brazil

http://dx.doi.org/10.1590/1806-9282.61.05.389

In the last edition of 2014, we used this very section to discuss the Journal of the Brazilian Medical Association’s (Ramb,

Revista da Associação Médica Brasileira)new pathways,

through an editorial in which we presented plans aiming at its consolidation among the country’s most relevant scientific publications.

Today, almost a year later, we have something to cel-ebrate. There has been an increase in Ramb’s impact fac-tor: from 0.915, as measured in 2013, to 0.933 in 2014, a result that places Ramb among the 20 most cited Brazil-ian journals. This information was reported by the Jour-nal Citation Reports (JCR) and published by the ISI WEB of Knowledge portal page on June 18, based on citation statistics of 2014. This is the second consecutive year that Ramb grows in impact factor. In 2012, Ramb’s impact factor calculated using the same criteria adopted by the JCR was 0.771, that is, Ramb has increased its number of citations by 0.162 in just two years.

The impact factor is known to be a measure that dem-onstrates the average number of citations of scientific ar-ticles published in a given journal, serving as a parame-ter to evaluate and compare journals from a common area. The higher the impact factor of a journal, the bet-ter its chances of having an article cited. In addition to the JCR (Science Citation), which assesses journals, Ramb is also included in the SJR SCImago (Journal & Country Rank, Scopus/Elsevier database), with 0,267 (2013) indi-cator value, and ranked as Qualis/Capes category B2. It is also indexed on the Lilacs, PubMed (Medline), Scopus and SciELo databases.

This result is important for Ramb and shows that we are on track towards increasing its reach year after year. We believe that strategies such as the plan to issue a month-ly journal, to prepare special themed editions, reformu-late the current proofreading process and change the

sub-mission process to give more flexibility to the development of articles can help to raise even more this impact factor.

Thus, since the beginning of August, Ramb has a new article submission mechanism. It is called ScholarOne, a platform certified by SciELO through a partnership with Thomson Reuters, one of the most reputable scientific information platforms, employed by journals through-out the world.

The advantages that ScholarOne provides authors and us, editors administratively, greatly optimizing the flow of articles, will allow Ramb to gain more agility, favoring all. The ScholarOne is currently used by over 500 institu-tions, 3,400 journals worldwide, supporting over 13 mil-lion users. In addition to features that significantly reduce time in the flowchart of submissions, it offers plagiarism detection, automated citation hyperlink to PubMed, send-ing of multimedia files, and online database FAQ, allow-ing research various subjects for basic submission tasks.

Access to the platform is done through the new Ramb website (www.ramb.org.br), launched last May. By clicking

on submit article, in the main menu, the author will be

re-directed to the ScholarOne platform. In addition to this facility, the new website is more up-to-date, with a sleek enjoyable look, as well as quite objective. It features search tools to previous editions of Ramb, which from this point on will be available online only, together with all the ma-terial made available to date by the SciELo. There is also a section to present news, links to other clinical guidelines produced by the Brazilian Medical Association (AMB, As-sociação Médica Brasileira) and specialties, norms for the publication of journal supplements, norms to write arti-cles, and online access for article submission.

Referências

Documentos relacionados

Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt- Muenster Group?. Cairo MS, Raetz E, Lim

A study of elderly persons living in the community in São Paulo showed higher scores in the domains of so- cial aspects, mental health, general health and vitality (70.2, 66.4,

With regard to the lower biochemical relapse rate found in patients treated with brachytherapy in this study in relation to those undergoing radical prostatectomy, this

Conclusion: it is concluded that the use of atropine and activated charcoal is highly effective to treat the signs and symptoms developed by patients present- ing acute

Laparoscopic vaginal vault closure with conventional straight instruments in single-port access total laparoscopic hysterectomy. Obstet

But the low rates of acceptance of suggestions, such as “The advocacy role of nurses is defined in health system as an independent role like a policy maker role in order to de-

In this study, SNPs in estrogen recep- tor alpha (ESR1), cholesterol ester transfer protein (CETP) and lipoprotein lipase (LPL) show significant baseline plasma effects

Due to the low likelihood of ovarian cancer in incidental findings of adnexal pelvic masses, and because of the high rates of spontaneous resolution, ultrasound monitoring can